阿鲁米斯 ALMS
$6.03 +$0.18 (+3.08%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $6.03 0.00%
开盘$5.88
昨收$5.85
当日区间$5.82 – $6.08
成交量1.28M
市值$780.49M
市盈率（TTM）–
股息率–
ALMS 相关新闻
匹配 Alumis 或代码 ALMS 的头条新闻，按最新排序。
- Analysts' Top Healthcare Picks: UniQure (QURE), Alumis Inc. (ALMS)
- Raymond James Maintains Alumis(ALMS.US) With Buy Rating
- Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Alumis Inc. (ALMS)
- A Quick Look at Today's Ratings for Alumis(ALMS.US), With a Forecast Between $15 to $37
- Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)
- Wells Fargo Sticks to Its Buy Rating for Alumis Inc. (ALMS)
- Alumis(ALMS.US) Director Buys US$10.73 Million in Common Stock
- Wells Fargo Maintains Alumis(ALMS.US) With Buy Rating, Maintains Target Price $25
- Morgan Stanley Maintains Alumis(ALMS.US) With Buy Rating, Maintains Target Price $39
- Analysts Offer Insights on Healthcare Companies: Alumis Inc. (ALMS), Cabaletta Bio (CABA) and Capricor Therapeutics (CAPR)
- Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE), Satellos Bioscience (MSLE) and Alumis Inc. (ALMS)
- Guggenheim Keeps Their Buy Rating on Alumis Inc. (ALMS)
- Stifel Maintains Alumis(ALMS.US) With Buy Rating, Maintains Target Price $44
- Guggenheim Maintains Alumis(ALMS.US) With Buy Rating, Maintains Target Price $34
- Alumis Inc. (ALMS) Receives a Rating Update From a Top Analyst
暂无评论——快来第一个聊聊 ALMS。